{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:43:53Z","timestamp":1792590233718,"version":"4.5.0"},"reference-count":44,"publisher":"MyJove Corporation","issue":"229","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70162","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T23:00:23Z","timestamp":1774652423000},"source":"Crossref","is-referenced-by-count":0,"title":["Isolation, Cultivation, and Transient Transfection of Primary Human T Cells to Generate Chimeric Antigen Receptor (CAR) T Cells"],"prefix":"10.3791","author":[{"given":"Elisabeth A.","family":"Lehner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanna M.","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Haberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolina","family":"Skvorc-Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M. S.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte U.","family":"Zajc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"e5430","DOI":"10.1371\/journal.pone.0005430","type":"journal-article","article-title":"Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells","volume":"4","author":"Bartelt","year":"2009","unstructured":"Bartelt, R. R., Cruz-Orcutt, N., Collins, M., Houtman, J. C. Comparison of T cell receptor-induced proximal signaling and downstream functions in immortalized and primary T cells. PLoS One. 4 (5), e5430 (2009).","journal-title":"PLoS One"},{"issue":"12","key":"ref2","type":"journal-article","article-title":"Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling","volume":"13","author":"Smeets","year":"2012","unstructured":"Smeets, R. L. et al. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. BMC Immunol. 13 (12) (2012).","journal-title":"BMC Immunol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"22426","DOI":"10.1038\/s41598-025-95903-0","type":"journal-article","article-title":"Jurkat T-cell lines exhibit marked genomic instability affecting karyotype, mutational profile, gene expression, immunophenotype and function","volume":"15","author":"Wilson","year":"2025","unstructured":"Wilson, A. et al. Jurkat T-cell lines exhibit marked genomic instability affecting karyotype, mutational profile, gene expression, immunophenotype and function. Sci Rep. 15 (1), 22426 (2025).","journal-title":"Sci Rep"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"100728","DOI":"10.1016\/j.crmeth.2024.100728","type":"journal-article","article-title":"An engineering strategy to target activated EGFR with CAR T cells","volume":"4","author":"Dobersberger","year":"2024","unstructured":"Dobersberger, M. et al. An engineering strategy to target activated EGFR with CAR T cells. Cell Rep Methods. 4 (4), 100728 (2024).","journal-title":"Cell Rep Methods"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood.2018885863","type":"journal-article","article-title":"Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy","volume":"134","author":"Van Bruggen","year":"2019","unstructured":"Van Bruggen, J. A. C. et al. Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy. Blood. 134 (1), 44-58 (2019).","journal-title":"Blood"},{"issue":"1956","key":"ref6","type":"journal-article","article-title":"Differences in expansion potential of naive chimeric antigen receptor T cells from healthy donors and untreated chronic lymphocytic leukemia patients","volume":"8","author":"Hoffmann","year":"2017","unstructured":"Hoffmann, J. M. et al. Differences in expansion potential of naive chimeric antigen receptor T cells from healthy donors and untreated chronic lymphocytic leukemia patients. Front Immunol. 8 (1956) (2017).","journal-title":"Front Immunol"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41467-023-36126-7","type":"journal-article","article-title":"Enhancing CAR-T cell functionality in a patient-specific manner","volume":"14","author":"Zhang","year":"2023","unstructured":"Zhang, D. K. Y. et al. Enhancing CAR-T cell functionality in a patient-specific manner. Nat Commun. 14 (1), 506 (2023).","journal-title":"Nat Commun"},{"issue":"104","key":"ref8","type":"journal-article","article-title":"Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation","volume":"8","author":"Li","year":"2010","unstructured":"Li, Y., Kurlander, R. J. Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation. J Transl Med. 8 (104) (2010).","journal-title":"J Transl Med"},{"issue":"50","key":"ref9","doi-asserted-by":"crossref","first-page":"82354","DOI":"10.18632\/oncotarget.10510","type":"journal-article","article-title":"Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo","volume":"7","author":"Xu","year":"2016","unstructured":"Xu, X. J. et al. Multiparameter comparative analysis reveals differential impacts of various cytokines on CART cell phenotype and function ex vivo and in vivo. Oncotarget. 7 (50), 82354-82368 (2016).","journal-title":"Oncotarget"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood-2005-12-4827","type":"journal-article","article-title":"Differential regulation of T-cell growth by IL-2 and IL-15","volume":"108","author":"Cornish","year":"2006","unstructured":"Cornish, G. H., Sinclair, L. V., Cantrell, D. A. Differential regulation of T-cell growth by IL-2 and IL-15. Blood. 108 (2), 600-608 (2006).","journal-title":"Blood"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s13238-019-0643-y","type":"journal-article","article-title":"Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects","volume":"10","author":"Zhou","year":"2019","unstructured":"Zhou, J. et al. Chimeric antigen receptor T (CAR-T) cells expanded with IL-7\/IL-15 mediate superior antitumor effects. Protein Cell. 10 (10), 764-769 (2019).","journal-title":"Protein Cell"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2019.01.018","type":"journal-article","article-title":"The emerging role of in vitro-transcribed mRNA in adoptive T cell immunotherapy","volume":"27","author":"Foster","year":"2019","unstructured":"Foster, J. B., Barrett, D. M., Kariko, K. The emerging role of in vitro-transcribed mRNA in adoptive T cell immunotherapy. Mol Ther. 27 (4), 747-756 (2019).","journal-title":"Mol Ther"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.omto.2023.05.007","type":"journal-article","article-title":"Enhancing the effectiveness of gammadelta T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers","volume":"29","author":"Becker","year":"2023","unstructured":"Becker, S. A. et al. Enhancing the effectiveness of gammadelta T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers. Mol Ther Oncolytics. 29, 145-157 (2023).","journal-title":"Mol Ther Oncolytics"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/cancers11081198","type":"journal-article","article-title":"Clinical-scale production of CAR-T cells for the treatment of melanoma patients by mRNA transfection of a CSPG4-specific CAR under full GMP compliance","volume":"11","author":"Wiesinger","year":"2019","unstructured":"Wiesinger, M. et al. Clinical-scale production of CAR-T cells for the treatment of melanoma patients by mRNA transfection of a CSPG4-specific CAR under full GMP compliance. Cancers (Basel). 11 (8), 1198 (2019).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tibtech.2023.08.005","type":"journal-article","article-title":"Chimeric antigen receptor therapy meets mRNA technology","volume":"42","author":"Wu","year":"2024","unstructured":"Wu, J., Wu, W., Zhou, B., Li, B. Chimeric antigen receptor therapy meets mRNA technology. Trends Biotechnol. 42 (2), 228-240 (2024).","journal-title":"Trends Biotechnol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrd4278","type":"journal-article","article-title":"mRNA-based therapeutics--developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","unstructured":"Sahin, U., Kariko, K., Tureci, O. mRNA-based therapeutics--developing a new class of drugs. Nat Rev Drug Discov. 13 (10), 759-780 (2014).","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/immunohorizons.2400008","type":"journal-article","article-title":"T cell activators exhibit distinct downstream effects on chimeric antigen receptor T cell phenotype and function","volume":"8","author":"Underwood","year":"2024","unstructured":"Underwood, S. et al. T cell activators exhibit distinct downstream effects on chimeric antigen receptor T cell phenotype and function. Immunohorizons. 8 (6), 404-414 (2024).","journal-title":"Immunohorizons"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-0716-2285-8_9","type":"journal-article","article-title":"Affinity and stability analysis of yeast displayed proteins","volume":"2491","author":"Zajc","year":"2022","unstructured":"Zajc, C. U., Teufl, M., Traxlmayr, M. W. Affinity and stability analysis of yeast displayed proteins. Methods Mol Biol. 2491, 155-173 (2022).","journal-title":"Methods Mol Biol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"23024","DOI":"10.1038\/s41598-023-48528-0","type":"journal-article","article-title":"Solving the mystery of the FMC63-CD19 affinity","volume":"13","author":"Seigner","year":"2023","unstructured":"Seigner, J. et al. Solving the mystery of the FMC63-CD19 affinity. Sci Rep. 13 (1), 23024 (2023).","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.semcdb.2014.05.018","type":"journal-article","article-title":"Determinants and implications of mRNA poly(A) tail size--does this protein make my tail look big","volume":"34","author":"Jalkanen","year":"2014","unstructured":"Jalkanen, A. L., Coleman, S. J., Wilusz, J. Determinants and implications of mRNA poly(A) tail size--does this protein make my tail look big? Semin Cell Dev Biol. 34, 24-32 (2014).","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/hum.2018.145","type":"journal-article","article-title":"Purification of mRNA encoding a chimeric antigen receptor is critical for the generation of a robust T-Cell response","volume":"30","author":"Foster","year":"2019","unstructured":"Foster, J. B. et al. Purification of mRNA encoding a chimeric antigen receptor is critical for the generation of a robust T-Cell response. Hum Gene Ther. 30 (2), 168-178 (2019).","journal-title":"Hum Gene Ther"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/ijms26030965","type":"journal-article","article-title":"Optimal chimeric antigen receptor (CAR)-mRNA for transient CAR T cell generation","volume":"26","author":"Kitte","year":"2025","unstructured":"Kitte, R. et al. Optimal chimeric antigen receptor (CAR)-mRNA for transient CAR T cell generation. Int J Mol Sci. 26 (3), 965 (2025).","journal-title":"Int J Mol Sci"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/s41596-020-00467-0","type":"journal-article","article-title":"Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity","volume":"16","author":"Kiesgen","year":"2021","unstructured":"Kiesgen, S., Messinger, J. C., Chintala, N. K., Tano, Z., Adusumilli, P. S. Comparative analysis of assays to measure CAR T-cell-mediated cytotoxicity. Nat Protoc. 16 (3), 1331-1342 (2021).","journal-title":"Nat Protoc"},{"issue":"216","key":"ref24","first-page":"e67548","type":"journal-article","article-title":"A nonviral approach to generate transient chimeric antigen receptor T cells using mRNA for cancer immunotherapy","author":"Hu","year":"2025","unstructured":"Hu, L. et al. A nonviral approach to generate transient chimeric antigen receptor T cells using mRNA for cancer immunotherapy. J Vis Exp. 216, e67548 (2025).","journal-title":"J Vis Exp"},{"issue":"10","key":"ref25","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1093\/neuonc\/noaf115","type":"journal-article","article-title":"Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models","volume":"27","author":"Foster","year":"2025","unstructured":"Foster, J. B. et al. Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high grade glioma models. Neuro Oncol. 27 (10), 2684-2696 (2025).","journal-title":"Neuro Oncol"},{"issue":"217","key":"ref26","first-page":"e67657","type":"journal-article","article-title":"Droplet-based cytotoxicity assay to assess chimeric antigen receptor T cells at the single-cell level","author":"Usheva","year":"2025","unstructured":"Usheva, Z. I., Petersen, D. L., Barington, T., Mouritzen, P., Barnkob, M. B. Droplet-based cytotoxicity assay to assess chimeric antigen receptor T cells at the single-cell level. J Vis Exp. (217), e67657 (2025).","journal-title":"J Vis Exp"},{"issue":"200","key":"ref27","first-page":"e65560","type":"journal-article","article-title":"Rapid in vitro cytotoxicity evaluation of Jurkat expressing chimeric antigen receptor using fluorescent imaging","author":"Subham","year":"2023","unstructured":"Subham, S. et al. Rapid in vitro cytotoxicity evaluation of Jurkat expressing chimeric antigen receptor using fluorescent imaging. J Vis Exp. (200), e65560 (2023).","journal-title":"J Vis Exp"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymthe.2005.07.688","type":"journal-article","article-title":"High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation","volume":"13","author":"Zhao","year":"2006","unstructured":"Zhao, Y. et al. High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation. Mol Ther. 13 (1), 151-159 (2006).","journal-title":"Mol Ther"},{"issue":"24","key":"ref29","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1182\/blood-2014-01-552174","type":"journal-article","article-title":"Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15","volume":"123","author":"Xu","year":"2014","unstructured":"Xu, Y. et al. Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15. Blood. 123 (24), 3750-3759 (2014).","journal-title":"Blood"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1078\/0171-2985-00219","type":"journal-article","article-title":"Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells","volume":"207","author":"Clausen","year":"2003","unstructured":"Clausen, J. et al. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology. 207 (2), 85-93 (2003).","journal-title":"Immunobiology"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/imcb.12636","type":"journal-article","article-title":"T-cell activation-induced marker assays in health and disease","volume":"101","author":"Poloni","year":"2023","unstructured":"Poloni, C. et al. T-cell activation-induced marker assays in health and disease. Immunol Cell Biol. 101 (6), 491-503 (2023).","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"103343","DOI":"10.1016\/j.xpro.2024.103343","type":"journal-article","article-title":"Protocol for flow cytometry immunophenotyping of human antigen-specific T cells by activation-induced marker and Th1 cytokine detection","volume":"6","author":"Rotta","year":"2025","unstructured":"Rotta, G. et al. Protocol for flow cytometry immunophenotyping of human antigen-specific T cells by activation-induced marker and Th1 cytokine detection. STAR Protoc. 6 (1), 103343 (2025).","journal-title":"STAR Protoc"},{"issue":"20","key":"ref33","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","type":"journal-article","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA adverse events reporting system","volume":"143","author":"Elsallab","year":"2024","unstructured":"Elsallab, M. et al. Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA adverse events reporting system. Blood. 143 (20), 2099-2105 (2024).","journal-title":"Blood"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMp2400209","type":"journal-article","article-title":"Secondary cancers after chimeric antigen receptor T-cell therapy","volume":"390","author":"Verdun","year":"2024","unstructured":"Verdun, N., Marks, P. Secondary cancers after chimeric antigen receptor T-cell therapy. N Engl J Med. 390 (7), 584-586 (2024).","journal-title":"N Engl J Med"},{"issue":"12","key":"ref35","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00262-015-1767-4","type":"journal-article","article-title":"Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone","volume":"64","author":"Krug","year":"2015","unstructured":"Krug, C. et al. Stability and activity of MCSP-specific chimeric antigen receptors (CARs) depend on the scFv antigen-binding domain and the protein backbone. Cancer Immunol Immunother. 64 (12), 1623-1635 (2015).","journal-title":"Cancer Immunol Immunother"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"101139","DOI":"10.1016\/j.omtm.2023.101139","type":"journal-article","article-title":"Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering","volume":"31","author":"Kitte","year":"2023","unstructured":"Kitte, R. et al. Lipid nanoparticles outperform electroporation in mRNA-based CAR T cell engineering. Mol Ther Methods Clin Dev. 31, 101139 (2023).","journal-title":"Mol Ther Methods Clin Dev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-3770-8_10","type":"journal-article","article-title":"Electroporation of mRNA as a universal technology platform to transfect a variety of primary cells with antigens and functional proteins","volume":"2786","author":"Sauerer","year":"2024","unstructured":"Sauerer, T. et al. Electroporation of mRNA as a universal technology platform to transfect a variety of primary cells with antigens and functional proteins. Methods Mol Biol. 2786, 219-235 (2024).","journal-title":"Methods Mol Biol"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011759","type":"journal-article","article-title":"T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles","volume":"13","author":"Bimbo","year":"2025","unstructured":"Bimbo, J. F. et al. T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles. J Immunother Cancer. 13 (7), (2025).","journal-title":"J Immunother Cancer"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/10409238.2017.1304354","type":"journal-article","article-title":"Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side","volume":"52","author":"Hudecek","year":"2017","unstructured":"Hudecek, M. et al. Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side. Crit Rev Biochem Mol Biol. 52 (4), 355-380 (2017).","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-1-0716-2441-8_2","type":"journal-article","article-title":"Minicircles for CAR T cell production by sleeping beauty transposition: a technological overview","volume":"2521","author":"Prommersberger","year":"2022","unstructured":"Prommersberger, S. et al. Minicircles for CAR T cell production by sleeping beauty transposition: a technological overview. Methods Mol Biol. 2521, 25-39 (2022).","journal-title":"Methods Mol Biol"},{"issue":"R1","key":"ref41","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1093\/hmg\/ddr140","type":"journal-article","article-title":"The Sleeping Beauty transposon system: a non-viral vector for gene therapy","volume":"20","author":"Aronovich","year":"2011","unstructured":"Aronovich, E. L., McIvor, R. S., Hackett, P. B. The Sleeping Beauty transposon system: a non-viral vector for gene therapy. Hum Mol Genet. 20 (R1), R14-20 (2011).","journal-title":"Hum Mol Genet"},{"issue":"18","key":"ref42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186514","type":"journal-article","article-title":"In vitro-Transcribed mRNA chimeric antigen receptor T cell (IVT mRNA CAR T) therapy in hematologic and solid tumor management: A preclinical update","volume":"21","author":"Soundara Rajan","year":"2020","unstructured":"Soundara Rajan, T., Gugliandolo, A., Bramanti, P., Mazzon, E. In vitro-Transcribed mRNA chimeric antigen receptor T cell (IVT mRNA CAR T) therapy in hematologic and solid tumor management: A preclinical update. Int J Mol Sci. 21 (18), (2020).","journal-title":"Int J Mol Sci"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1474-4422(23)00194-1","type":"journal-article","article-title":"Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b\/2a study","volume":"22","author":"Granit","year":"2023","unstructured":"Granit, V. et al. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b\/2a study. Lancet Neurol. 22 (7), 578-590 (2023).","journal-title":"Lancet Neurol"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"102676","DOI":"10.1016\/j.omtn.2025.102676","type":"journal-article","article-title":"Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma","volume":"36","author":"Dagher","year":"2025","unstructured":"Dagher, O. K. et al. Preclinical efficacy of multi-targeting mRNA-based CAR T cell therapy in resection models of glioblastoma. Mol Ther Nucleic Acids. 36 (3), 102676 (2025).","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70162\/isolation-cultivation-transient-transfection-primary-human-t-cells-to","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:07:56Z","timestamp":1792588076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70162\/isolation-cultivation-transient-transfection-primary-human-t-cells-to"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":44,"journal-issue":{"issue":"229","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70162","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]}}}